STOCK TITAN

Mark N. Rogers plans 5,000-share AMKR sale (AMKR) via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark N. Rogers submitted a Form 144 reporting an intended sale of 5,000 shares of Common Stock of AMKR on 04/16/2026 via a stock option exercise with cash proceeds. The filing also lists prior sales of 5,000 shares on 03/16/2026 for $222,700 and 5,000 shares on 02/17/2026 for $234,600.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice of proposed resale following option exercise.

The filing lists an intended sale of 5,000 common shares on 04/16/2026 tied to a stock option exercise. This is a standard disclosure that provides timing and amounts of a planned disposition by a reporting person.

Prior sales on 03/16/2026 and 02/17/2026 are disclosed with gross proceeds of $222,700 and $234,600, respectively. The filing does not state trading plan status or post-transaction holdings.

Planned sale 5,000 shares Intended sale on <date>04/16/2026</date> via stock option exercise
Proceeds (03/16/2026) $222,700 5,000 shares sold on <date>03/16/2026</date>
Proceeds (02/17/2026) $234,600 5,000 shares sold on <date>02/17/2026</date>
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
stock option exercise financial
"Common | 04/16/2026 | Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
issuer regulatory
"Stock Option Exercise | ISSUER"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Mark N. Rogers' Form 144 for AMKR report?

It reports an intended sale of 5,000 shares of AMKR on 04/16/2026 tied to a stock option exercise. The form lists prior sales of two separate 5,000-share blocks in February and March 2026.

How much proceeds were reported for recent AMKR sales by the filer?

The filing shows proceeds of $222,700 for a 5,000-share sale on 03/16/2026 and $234,600 for a 5,000-share sale on 02/17/2026. The intended April sale lists 5,000 shares.

What method is the April 16, 2026 AMKR sale reported as?

The April sale is reported as occurring via a stock option exercise with cash proceeds. The filing identifies the transaction type as a stock option exercise on 04/16/2026.

Does the Form 144 state whether proceeds go to the issuer or selling holder?

The April entry lists the transaction as a Stock Option Exercise and indicates ISSUER in the form's method field. The filing does not elaborate further on proceeds allocation beyond that label.

Is there disclosure of a trading plan or Rule 10b5-1 in this Form 144?

The provided excerpt does not include any statement about a Rule 10b5-1 trading plan or pre-arranged plan. The filing lists transaction dates and amounts without referencing a trading plan.